BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:OCT-598 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of OCT-598\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07358806-2651@assetmemo.bio
DTSTAMP:20261121T005821Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:OCT-598: Phase 1 readout est. (NCT07358806)
DESCRIPTION:OCT-598\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: Study t
 o Assess the Effect of OCT-598 in Patients With Advanced Solid Tumors\nEst
 imated primary completion: December 2027. This is a ClinicalTrials.gov est
 imate\, not a confirmed readout date\, and it can move.\nDrug page: https:
 //assetmemo.bio/drug/oct-598#upcoming-events\nRegistry record: https://cli
 nicaltrials.gov/study/NCT07358806
URL:https://assetmemo.bio/drug/oct-598#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
